Lab
Laboratory Corporation of America
Laboratory Corporation of America was paid $2.73M by Medicaid between Nov 2023 and Dec 2024, across 196 billing codes. Its largest line is 0352U, — 9.2% of everything it billed.
33Billing provider infoLABORATORY CORPORATION OF AMERICA
PORTLAND, OR 97232
PORTLAND, OR 97232
33aNPI1871275081assigned 08/07/2023
33bProvider typeClinical Medical Laboratory
28Total paid$2.73M
24GClaims317,345
24DCodes billed196
24AFirst – last monthNov 2023 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Oregon
Rank by total paid#11 of 46
Median peer was paid$50K
This provider vs. median55×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 34,617 | $203K | |
| 2024incomplete | 282,728 | $2.53M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0352U | 9.2% | 5,086 | 4,913 | $253K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7.5% | 9,571 | 9,291 | $204K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7.4% | 9,548 | 9,269 | $203K |
| 80050 | General health panel | 4.0% | 4,162 | 4,026 | $110K |
| 36415 | Collection of venous blood by venipuncture | 3.9% | 29,328 | 27,210 | $105K |
| 80053 | Comprehensive metabolic panel | 3.6% | 18,720 | 17,793 | $99K |
| 80061 | Lipid panel | 3.2% | 13,269 | 12,905 | $89K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.1% | 6,203 | 6,056 | $86K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.1% | 9,892 | 9,652 | $86K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.9% | 2,135 | 1,960 | $80K |
| 82728 | 2.7% | 9,795 | 9,566 | $74K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.4% | 16,985 | 15,976 | $65K |
184 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.4% | 4,716 | $64K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.3% | 13,104 | $62K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.0% | 11,984 | $55K |
| 86780 | 1.9% | 6,485 | $51K | |
| 87625 | 1.8% | 2,139 | $50K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.6% | 2,745 | $44K |
| 86803 | 1.4% | 4,796 | $39K | |
| 86003 | 1.2% | 509 | $34K | |
| 88142 | 1.2% | 2,796 | $34K | |
| 84403 | 1.2% | 2,132 | $32K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.1% | 560 | $31K |
| 82607 | 1.1% | 4,023 | $31K | |
| 86480 | <1% | 714 | $24K | |
| 84439 | <1% | 5,048 | $24K | |
| 82670 | <1% | 1,426 | $24K | |
| 83550 | <1% | 4,867 | $23K | |
| 87186 | <1% | 4,096 | $19K | |
| 83540 | <1% | 5,023 | $17K | |
| 84402 | <1% | 1,166 | $17K | |
| 87340 | <1% | 2,900 | $17K | |
| 87070 | <1% | 3,384 | $17K | |
| 86258 | <1% | 771 | $15K | |
| 84270 | <1% | 1,176 | $14K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 688 | $14K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 669 | $14K |
| 84153 | <1% | 1,484 | $14K | |
| 87077 | <1% | 3,221 | $13K | |
| 87088 | <1% | 3,147 | $13K | |
| 83001 | <1% | 1,133 | $12K | |
| 82746 | <1% | 1,604 | $12K | |
| 86762 | <1% | 1,448 | $12K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 147 | $12K |
| 87536 | <1% | 275 | $12K | |
| 87529 | <1% | 527 | $11K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,092 | $11K |
| 87081 | <1% | 2,620 | $11K | |
| 86850 | <1% | 1,838 | $10K | |
| 84702 | <1% | 1,119 | $10K | |
| 86364 | <1% | 1,433 | $10K | |
| 84481 | <1% | 1,039 | $10K | |
| 83880 | <1% | 623 | $9K | |
| 82570 | <1% | 3,808 | $9K | |
| 82784 | <1% | 1,545 | $9K | |
| 83970 | <1% | 672 | $9K | |
| 86317 | <1% | 1,087 | $9K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 401 | $8K |
| 84146 | <1% | 747 | $8K | |
| 80074 | <1% | 308 | $8K | |
| 83002 | <1% | 660 | $7K | |
| 87205 | <1% | 3,047 | $7K | |
| 86140 | <1% | 2,461 | $7K | |
| 87522 | Neg quan hep c or qual rna | <1% | 314 | $7K |
| 87046 | <1% | 605 | $7K | |
| G0307 | Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) | <1% | 2,190 | $7K |
| 85027 | <1% | 1,748 | $6K | |
| 86665 | <1% | 290 | $6K | |
| 83735 | <1% | 2,101 | $6K | |
| 84144 | <1% | 472 | $6K | |
| 83993 | <1% | 497 | $6K | |
| 86231 | <1% | 756 | $5K | |
| 82043 | <1% | 2,060 | $5K | |
| 86376 | <1% | 670 | $5K | |
| 83655 | <1% | 678 | $5K | |
| 82627 | <1% | 388 | $5K | |
| 82785 | <1% | 523 | $5K | |
| 81001 | <1% | 3,204 | $5K | |
| 87338 | <1% | 552 | $4K | |
| 82951 | <1% | 525 | $4K | |
| 82274 | <1% | 502 | $4K | |
| 84425 | <1% | 339 | $4K | |
| 86038 | <1% | 805 | $4K | |
| 86704 | <1% | 629 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 222 | $4K |
| 82533 | <1% | 425 | $4K | |
| 85652 | <1% | 2,400 | $4K | |
| 86800 | <1% | 421 | $4K | |
| 87427 | <1% | 563 | $3K | |
| 83690 | <1% | 841 | $3K | |
| 84156 | <1% | 1,819 | $3K | |
| 86696 | <1% | 289 | $3K | |
| 82950 | <1% | 1,039 | $3K | |
| 84480 | <1% | 415 | $3K | |
| 80076 | <1% | 684 | $3K | |
| 80069 | <1% | 966 | $3K | |
| 86359 | <1% | 164 | $3K | |
| 87045 | <1% | 563 | $3K | |
| 86664 | <1% | 278 | $3K | |
| 83498 | <1% | 137 | $2K | |
| 85041 | <1% | 1,306 | $2K | |
| 83525 | <1% | 361 | $2K | |
| 86900 | <1% | 1,398 | $2K | |
| 86901 | <1% | 1,398 | $2K | |
| 86160 | <1% | 219 | $2K | |
| 87177 | <1% | 479 | $2K | |
| 83521 | <1% | 117 | $2K | |
| 82105 | <1% | 313 | $2K | |
| 86663 | <1% | 282 | $2K | |
| 86695 | <1% | 276 | $2K | |
| 85014 | <1% | 1,469 | $2K | |
| 85018 | <1% | 1,424 | $2K | |
| 86677 | <1% | 249 | $2K | |
| 86141 | <1% | 302 | $2K | |
| 86361 | <1% | 164 | $2K | |
| 85048 | <1% | 1,192 | $2K | |
| 84100 | <1% | 916 | $2K | |
| 85610 | <1% | 885 | $2K | |
| 86200 | <1% | 267 | $2K | |
| 80197 | <1% | 433 | $2K | |
| 82977 | <1% | 414 | $2K | |
| 83520 | <1% | 175 | $2K | |
| 83721 | <1% | 349 | $2K | |
| 84550 | <1% | 786 | $2K | |
| 86787 | <1% | 217 | $2K | |
| 82172 | <1% | 124 | $2K | |
| 86431 | <1% | 488 | $1K | |
| 87799 | <1% | 149 | $1K | |
| 80164 | <1% | 269 | $1K | |
| 83090 | <1% | 160 | $1K | |
| 86304 | <1% | 109 | $1K | |
| 83921 | <1% | 164 | $1K | |
| 87324 | <1% | 184 | $1K | |
| 82248 | <1% | 515 | $1K | |
| 82550 | <1% | 335 | $1K | |
| 82247 | <1% | 414 | $1K | |
| 80175 | <1% | 153 | $986.84 | |
| 83615 | <1% | 287 | $966.37 | |
| 84630 | <1% | 168 | $965.18 | |
| 82239 | <1% | 78 | $943.77 | |
| 81015 | <1% | 553 | $926.10 | |
| 84305 | <1% | 60 | $845.34 | |
| 87328 | <1% | 111 | $800.84 | |
| 82166 | <1% | 34 | $787.06 | |
| 87329 | <1% | 111 | $704.20 | |
| 80178 | <1% | 238 | $675.32 | |
| 86708 | <1% | 127 | $669.06 | |
| 82947 | <1% | 278 | $651.29 | |
| 85045 | <1% | 296 | $627.89 | |
| 85730 | <1% | 207 | $626.87 | |
| 84681 | <1% | 53 | $603.99 | |
| 87497 | <1% | 47 | $573.17 | |
| 86593 | <1% | 215 | $556.58 | |
| 85246 | <1% | 39 | $549.80 | |
| 84460 | <1% | 191 | $531.26 | |
| 84450 | <1% | 168 | $522.15 | |
| 82150 | <1% | 134 | $516.35 | |
| 84155 | <1% | 355 | $514.80 | |
| 82525 | <1% | 88 | $449.82 | |
| 85240 | <1% | 40 | $440.87 | |
| 82610 | <1% | 42 | $439.86 | |
| 84703 | <1% | 82 | $373.68 | |
| 84165 | <1% | 355 | $348.18 | |
| 82565 | <1% | 122 | $346.41 | |
| 87517 | <1% | 14 | $330.77 | |
| 85245 | <1% | 25 | $322.65 | |
| 82952 | <1% | 121 | $309.72 | |
| 84478 | <1% | 102 | $267.43 | |
| 87206 | <1% | 87 | $256.54 | |
| 80177 | <1% | 43 | $256.26 | |
| 85379 | <1% | 38 | $225.95 | |
| 82310 | <1% | 83 | $178.30 | |
| 86225 | <1% | 39 | $173.53 | |
| 82672 | <1% | 13 | $152.34 | |
| 86709 | <1% | 25 | $149.90 | |
| 84520 | <1% | 60 | $148.10 | |
| 82390 | <1% | 24 | $144.18 | |
| 82140 | <1% | 27 | $135.63 | |
| 84436 | <1% | 38 | $135.18 | |
| 82378 | <1% | 13 | $119.94 | |
| 85384 | <1% | 26 | $116.93 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 88 | $113.76 |
| 80159 | <1% | 13 | $112.88 | |
| 86147 | <1% | 14 | $106.92 | |
| 86300 | <1% | 12 | $105.38 | |
| 82040 | <1% | 43 | $97.62 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 12 | $97.35 |
| 84134 | <1% | 14 | $85.38 | |
| 82340 | <1% | 24 | $85.36 | |
| 82652 | <1% | 13 | $76.98 | |
| 86235 | <1% | 17 | $68.77 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 141 | $68.38 |
| 87101 | <1% | 12 | $59.55 | |
| 84075 | <1% | 14 | $35.88 | |
| 81003 | <1% | 31 | $30.03 | |
| 80329 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMS, KIMBERLY (VICE PRESIDENT)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.